☆ 4.6 Letter

More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)

Journal

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Volume 9, Issue 10, Pages 2126-2127

Publisher

WILEY-BLACKWELL

DOI: 10.1111/j.1538-7836.2011.04440.x

Keywords

-

Categories

Hematology Peripheral Vascular Disease

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Engineering, Chemical

An analogous scale model for laboratory mixing studies

J. Wu, L. Graham, S. Peacock, B. Nguyen, Y. Feng, M. Hurley, G. Short, D. Harris, W. Bruckard

Summary: This technical note demonstrates the use of a model gypsum scale system to study the impact of flow condition on scale growth in mixing tanks. Photos of uneven scale growth distribution in laboratory mixing tanks are presented. The results obtained in the laboratory are qualitatively consistent with observations in full-scale plants. Due to its cost-effectiveness and simplicity, this method can be employed in pilot testing for the optimization of agitator and tank design, taking scale mitigation into account.

MINERALS ENGINEERING (2023)

Add to Collection

Article Economics

Monitoring 'lemons': why lower productivity workers are sometimes monitored more closely

Marcus Dittrich, Silvio Staedter

Summary: In this study, workplace monitoring in a principal-agent model is analyzed, focusing on two types of workers with different productivity levels. The elasticity of the workers' effort-cost function and the firm's monitoring-cost function are found to affect the monitoring intensity. Results suggest that the firm may monitor the low-productive worker more closely than the high-productive worker.

APPLIED ECONOMICS LETTERS (2021)

Add to Collection

Review Hematology

Are the correct outcomes being measured in studies of oral anticoagulants? A systematic survey

Mei Wang, Zhiyuan Chen, Michael Wong, Lehana Thabane, Lawrence Mbuagbaw, Deborah Siegal, Gregoire Le Gal, Anne Holbrook

Summary: Research on oral anticoagulants tends to focus more on mortality, physiological/clinical domains, and adverse events, with less attention on life impact and resource utilization domains. Future research priorities include developing a core outcome set that represents all domains in oral anticoagulant research.

THROMBOSIS RESEARCH (2021)

Add to Collection

Article Hematology

Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant

Chiara Novelli, Paola Pradella, Maria Papandrea, Barbara Montaruli

Summary: This study investigated the effect of activated charcoal (DOAC-Stop, DS) as a DOAC-adsorbent on samples from DOACs treated and untreated patients. The results suggest that DS can effectively remove DOAC interference, leading to correct results in LA testing, which is essential for the evaluation of coagulation function and the diagnosis and management of APS patients.

BLOOD COAGULATION & FIBRINOLYSIS (2023)

Add to Collection

Article Immunology

More Than Two to Tango: Mesenchymal Cells Are Required for Early T Cell Development

Michele K. Anderson

Summary: This article discusses the importance of MHC class II-positive epithelium and mesenchyme cells for T-cell development in the thymus.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Urology & Nephrology

Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment

Ye Ji Ham, Eleanor Nicklason, Tony Wightman, Sarah Akom, Kieran Sandhu, Philip Harraka, Deb Colville, Andrew Catran, David Barit, David Langsford, Tim Pianta, Andrew Foote, Russell Buchanan, Heather Mack, Judy Savige

Summary: This study found that individuals with systemic lupus erythematosus (SLE) have a higher number and larger size of drusen compared to controls. SLE patients with renal impairment also had higher drusen counts and larger drusen. This suggests that complement factor H (CFH) could be a potential treatment target for SLE, especially in cases with renal involvement.

KIDNEY INTERNATIONAL REPORTS (2022)

Add to Collection

Article Soil Science

Are carbon-storing soils more sensitive to climate change? A laboratory evaluation for agricultural temperate soils

Tchodjowie P. Kpemoua, Sarah Leclerc, Pierre Barre, Sabine Houot, Valerie Pouteau, Cedric Plessis, Claire Chenu

Summary: Agroecological practices can increase soil organic carbon (SOC) stocks, but questions arise regarding the permanence of this storage in the context of climate change. Understanding SOC dynamics and its sensitivity to climatic events is necessary to anticipate carbon losses in terrestrial ecosystems. Investigating the potential limitations of carbon-storing soils under climate change is important for mitigating climate change impacts.

SOIL BIOLOGY & BIOCHEMISTRY (2023)

Add to Collection

Article Surgery

Re-operative parathyroidectomy: How many positive localization studies are required?

Kimberly M. Ramonell, Herbert Chen, Brenessa Lindeman, Jessica Fazendin

Summary: This study found that the number of localization studies prior to re-operative parathyroidectomy does not impact the surgical cure rates, and successful re-operative parathyroidectomy can be performed with minimal pre-operative scans in certain clinical contexts.

AMERICAN JOURNAL OF SURGERY (2021)

Add to Collection

Editorial Material Orthopedics

Editorial Commentary: More Clinical Trials Should Focus on Primary Prevention of Osteoarthritis: Disruptive Thinkers Are Required

Erik Hohmann

Summary: With increasing life expectancy and a rising prevalence of osteoarthritis, the number of individuals suffering from symptomatic degenerative arthritis is expected to significantly increase. Current nonoperative treatments focus on weight loss, exercise, therapy, and medication, but only a small percentage of studies are dedicated to disease prevention.

ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY (2021)

Add to Collection

Article Food Science & Technology

Genome-Wide Investigation and Functional Analysis Reveal That CsKCS3 and CsKCS18 Are Required for Tea Cuticle Wax Formation

Lilai Mo, Xinzhuan Yao, Hu Tang, Yan Li, Yujie Jiao, Yumei He, Yihe Jiang, Shiyu Tian, Litang Lu

Summary: Cuticular wax acts as a natural barrier against stresses on plant surfaces. This study investigates the mechanism of wax formation in tea leaves and identifies new candidate genes for improving tea quality and stress resistance.

FOODS (2023)

Add to Collection

Article Engineering, Civil

Macro- and Microscale Properties of Vibration Mixing Cement-Stabilized Macadam: Laboratory and Field Investigation

Xuelian Li, Yuhao Zhou, Jie Xu, Zuofei Ning, Aboelkasim Diab

Summary: This study compares the performance of cement-stabilized macadam (CSM) base prepared using vibration mixing (VM) technology with the traditional two-cylinder continuous mixing method. The results show that VM CSM has improved strength, uniformity, and reduced shrinkage strain. Microstructural analysis demonstrates better cement hydration and distribution of hydration products with VM technology. The test road also confirms better uniformity, pavement performance, and economic benefits of VM CSM.

IRANIAN JOURNAL OF SCIENCE AND TECHNOLOGY-TRANSACTIONS OF CIVIL ENGINEERING (2023)

Add to Collection

Article Medicine, General & Internal

Are laboratory evaluations required in every case admitted to the pediatric emergency department with epistaxis?

Songul Tomar Guneysu, Oksan Derinoz Guleryuz, Elif Ceylan, Ayla Akca Caglar, Ozlem Colak

Summary: Epistaxis is a mostly self-limiting condition among children, with a low annual incidence. Most cases present in autumn, with spontaneous cessation in the majority of patients. Laboratory tests should be considered for cases with chronic diseases, bilateral bleeding, active bleeding, and nontraumatic epistaxis.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Hematology

Performance characteristics of 5 numerical indexes in mixing test interpretation under coexistence of lupus anticoagulant and coagulation factor deficiency

Masato Matsuda, Yoshiki Hoshiyama, Kazuei Ogawa, Mari Emmi, Shuji Terai, Masato Moriyama

Summary: This study examined the differences in indexes based on factor VIII activity (FVIII:C) levels and lupus anticoagulant (LA) titers in test samples. The results showed that all indexes showed correction under FVIII deficiency and non-correction under higher LA titers. However, under lower LA titers, some indexes showed non-correction while others showed correction due to dilution effects and variations in formulas and/or sample mix ratios. These differences were more pronounced under coexistent FVIII deficiency and LA.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Add to Collection

Article Agronomy

More than 1000 genotypes are required to derive robust relationships between yield, yield stability and physiological parameters: a computational study on wheat crop

Tien-Cheng Wang, Pierre Casadebaig, Tsu-Wei Chen

Summary: Using in silico experiments in crop modeling, we studied the physiological regulations of yield and yield stability, as well as the necessary genotype and environment numbers for analyzing yield stability. Our findings suggest that a stability index (SI) may be influenced by the shape of phenotype distributions, and the genotypic superiority measure (P-i) is less affected among 11 SI. We also demonstrated that more than 150 environments are required to estimate yield stability convincingly, and more than 1000 genotypes are necessary to evaluate the contribution of a physiological parameter to yield stability.

THEORETICAL AND APPLIED GENETICS (2023)

Add to Collection

Article Multidisciplinary Sciences

All human social groups are human, but some are more human than others: A comprehensive investigation of the implicit association of Human to US racial/ethnic groups

Kirsten N. Morehouse, Keith Maddox, Mahzarin R. Banaji

Summary: Although all human groups are considered equal, there is a dissociation between implicit and explicit measures regarding racial/ethnic bias. White participants, despite affirming the equality of all racial/ethnic groups, consistently associated "Human" more with White than other groups. On the other hand, non-White participants showed no bias in associating "Human" with their own group. However, when faced with multiple outgroups, non-White participants displayed biases towards associating "Human" with White. This implicit bias was largely invariant across demographic variations but varied by political ideology and gender, with conservatives and men exhibiting stronger associations between "Human" and White.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Gender Related Differences in Gastrointestinal Bleeding With Oral Anticoagulation in Atrial Fibrillation

Eliana Ferroni, Gentian Denas, Nicola Gennaro, Ugo Fedeli, Vittorio Pengo

Summary: This study assessed the difference in gastrointestinal bleeding between males and females using DOACs and VKAs among patients with atrial fibrillation. The findings indicate that female patients using DOACs have a higher risk of gastrointestinal bleeding compared to male patients, while no significant difference was observed in VKA users.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2022)

Add to Collection

Review Hematology

Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review

Vittorio Pengo

Summary: Thrombotic antiphospholipid syndrome is characterized by thrombosis caused by antiphospholipid antibodies. Interaction between aPL and the protein C system may play a role in this syndrome. Acquired APC-R due to aPL could explain the clinical manifestations of APS.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2022)

Add to Collection

Article Rheumatology

Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey

Vittorio Pengo, Teresa Del Ross, Marta Tonello, Laura Andreoli, Angela Tincani, Paolo Gresele, Elena Silvestri, Paolo Simioni, Elena Campello, Ariela Hoxha, Anna Falanga, Angelo Ghirarduzzi, Gentian Denas

Summary: This nationwide multicenter survey evaluated the course of COVID-19 and adverse events after vaccination in patients with triple-positive thrombotic APS. The results showed that these patients did not suffer from severe COVID-19 outcomes and COVID-19 vaccination was well tolerated. These findings can help reassure patients and physicians and reduce hesitancy in unvaccinated individuals.

RHEUMATOLOGY (2022)

Add to Collection

Review Hematology

Prevalence of aPhosphatidylserine/prothrombin antibodies and association with antiphospholipid antibody profiles in patients with antiphospholipid syndrome: A systematic review and meta-analysis

Rui Zhu, Chun-Yan Cheng, Yan Yang, Gentian Denas, Vittorio Pengo

Summary: This systematic review evaluated the prevalence of phosphatidylserine/prothrombin complex autoantibodies (aPS/PT) in patients with antiphospholipid syndrome (APS). The results showed a high rate of aPS/PT positivity in patients with APS, especially in those positive for Lupus Anticoagulant (LAC). However, further studies are needed to determine whether this test might be useful in the laboratory classification criteria of APS.

THROMBOSIS RESEARCH (2022)

Add to Collection

Article Medicine, General & Internal

A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation

Giuseppe Patti, Vito Maurizio Parato, Ilaria Cavallari, Paolo Calabro, Vincenzo Russo, Giulia Renda, Felice Gragnano, Vittorio Pengo, Antonio D'Onofrio, Massimo Grimaldi, Raffaele De Caterina

Summary: Edoxaban therapy in patients with atrial fibrillation and left atrial thrombus is associated with a thrombus resolution rate of over 50% at 4 weeks. Edoxaban demonstrates comparable efficacy to other oral anticoagulants in thrombus dissolution.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Hematology

Antiphospholipid Syndrome in Patients with Venous Thromboembolism

Vittorio Pengo, Gentian Denas

Summary: Unprovoked or provoked by mild risk factors, VTE in young patients, VTE in uncommon sites, or cases of unexplained VTE recurrence may be positive for antiphospholipid antibodies (aPL) and thus may be diagnosed with antiphospholipid syndrome (APS). The evaluation of aPL is standardized using immunological tests for anticardiolipin and anti-beta 2-glycoprotein I. The determination of functional antibodies (lupus anticoagulant) is less standardized, especially in patients on anticoagulant treatment. Patients positive for all three tests are at high risk of recurrence, which may lead to chronic thromboembolic pulmonary hypertension. Randomized clinical trials have shown that triple-positive patients should be treated with vitamin K antagonists maintaining an international normalized ratio between 2 and 3. Whether patients with VTE and incomplete aPL profile can be treated with direct oral anticoagulants should be further investigated.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Add to Collection

Review Medicine, General & Internal

How we treat clinical dilemmas in antiphospholipid syndrome: A case-based approach

Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, Marta Arbrile, Alice Barinotti, Elena Rubini, Alessandro Morotti, Vittorio Pengo, Dario Roccatello, Savino Sciascia

Summary: Antiphospholipid syndrome (APS) is an autoimmune condition characterized by thrombosis and/or pregnancy morbidity in patients with persistent positive antiphospholipid antibodies (aPL). Patients who do not completely fulfill the classification criteria for overt APS may pose challenges in terms of treatment and management. This article aims to discuss therapeutic strategies based on available literature for challenging scenarios of aPL positive patients.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes Meta-Analysis of Randomized Trials

Candrika D. Khairani, Antoine Bejjani, Gregory Piazza, David Jimenez, Manuel Monreal, Saurav Chatterjee, Vittorio Pengo, Scott C. Woller, Josefina Cortes-Hernandez, Jean M. Connors, Yogendra Kanthi, Harlan M. Krumholz, Saskia Middeldorp, Anna Falanga, Mary Cushman, Samuel Z. Goldhaber, David A. Garcia, Behnood Bikdeli

Summary: A systematic review and meta-analysis of randomized controlled trials comparing direct oral anticoagulants (DOACs) with vitamin K antagonists (VKAs) for thrombotic antiphospholipid syndrome patients found that DOACs were associated with an increased risk of subsequent arterial thrombotic events compared to VKAs. However, there were no significant differences in the risk of subsequent venous thromboembolic events or major bleeding between the two groups.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension

Rui Zhu, Gang-Yi Cheng, Gentian Denas, Vittorio Pengo

Summary: Acquired thrombophilia, specifically antiphospholipid antibodies (aPL), may contribute to the development of chronic thromboembolic pulmonary hypertension (CTEPH). Young patients who experience an unprovoked pulmonary embolism (PE) or PE triggered by mild risk factors should be tested for aPL. If positive, close monitoring and lifelong anticoagulant therapy should be considered because aPL-induced thrombophilia increases the risk of recurrent PE leading to CTEPH. The presence of lupus anticoagulant (LAC), anti-cardiolipin (aCL), and anti-& beta;2-glycoprotein I (a & beta;2GPI) antibodies indicates the highest risk of recurrence and necessitates treatment with warfarin for maximum protection.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Add to Collection

Article Rheumatology

Fluctuation of Anti-Domain 1 and Anti-β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

Cecilia B. Chighizola, Francesca Pregnolato, Danieli Andrade, Maria Tektonidou, Vittorio Pengo, Guillermo Ruiz-Irastorza, H. Michael Belmont, Maria Gerosa, Paul Fortin, D. Ware Branch, Laura A. Andreoli, Michelle A. Petri, Ricard S. Cervera, Jason S. Knight, Rohan Willis, Maria Efthymiou, Hannah Cohen, Doruk Erkan, Maria Laura Bertolaccini

Summary: The study aims to evaluate the antibodies titers against beta(2)-glycoprotein I (anti-beta(2)GPI) and domain 1 (anti-D1) in a longitudinally manner. The results show that treatment with hydroxychloroquine (HCQ) is associated with a decrease in antibody titers, while incident vascular events are associated with an increase in antibody titers. The titers of antibodies are lower at the time of thrombosis. This study is of great importance in understanding the fluctuations in antibody titers and their relationship with thrombosis.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

Review Pharmacology & Pharmacy

New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond

Giovanni Santostasi, Gentian Denas, Vittorio Pengo

Summary: This article summarizes the progress made in using anticoagulation for stroke prevention in patients with non-valvular atrial fibrillation, with a particular focus on new drugs that can minimize bleeding risk in elderly patients.

EXPERT OPINION ON PHARMACOTHERAPY (2023)

Add to Collection

Article Medicine, Research & Experimental

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Elena Gkrouzman, Rohan Willis, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz-Irastorza, H. Michael Belmont, Paul R. Fortin, Maria Gerosa, Flavio Signorelli, Tatsuya Atsumi, D. Ware Branch, Cecilia Nalli, Esther Rodriguez-Almaraz, Michelle A. Petri, Ricard Cervera, Jason S. Knight, Maria Efthymiou, Hannah Cohen, Maria Laura Bertolaccini, Doruk Erkan, Robert Roubey

Summary: A study found that different profiles of antiphospholipid antibody (aPL) are associated with the clinical manifestations of antiphospholipid syndrome (APS), particularly higher levels of anticardiolipin antibody (aCL) and anti -b2 glycoprotein-I antibody (ab2GPI). The study also identified overlapping antibody detection methods and proposed a calculation method to assess the overall burden of aPL.

LABORATORY INVESTIGATION (2023)

Add to Collection

Article Rheumatology

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Gustavo G. M. Balbi, Yasaman Ahmadzadeh, Maria G. Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte, H. Michael Belmont, Chary Lopez-Pedrera, Paul R. Fortin, Denis Wahl, Maria Gerosa, Guilherme R. de Jesus, Lanlan Ji, Tatsuya Atsumi, Maria Efthymiou, D. Ware Branch, Cecilia Nalli, Esther Rodriguez Almaraz, Michelle Petri, Ricard Cervera, Jason S. Knight, Bahar Artim-Esen, Rohan Willis, Maria Laura Bertolaccini, Hannah Cohen, Robert Roubey, Doruk Erkan, Danieli Castro Oliveira de Andrade

Summary: The objective of this study was to quantify the damage burden measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in aPL-positive patients with or without a history of thrombosis, and to identify clinical and laboratory characteristics associated with damage in these patients. The study found that DIAPS is of great significance in identifying patients with a higher damage burden and selected traditional cardiovascular risk factors, steroid use, and specific aPL profiles may help in identifying these patients.

RHEUMATOLOGY (2023)

Add to Collection

Letter Hematology

Association between Severe Acute Respiratory Syndrome Coronavirus 2Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment

Marta Monti, Tiziano Martini, Vittorio Pengo, Giovanni Poletti, Paola Pedrazzi, Chiara Biasoli, Maddalena Giovacchini, Tommaso Fasano

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Add to Collection

Article Rheumatology

Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Yu Zuo, Sherwin Navaz, Alex Tsodikov, Katarina Kmetova, Lyndsay Kluge, Amala Ambati, Claire K. Hoy, Srilakshmi Yalavarthi, Danieli de Andrade, Maria G. Tektonidou, Savino Sciascia, Vittorio Pengo, Guillermo Ruiz-Irastorza, H. Michael Belmont, Maria Gerosa, Paul R. Fortin, Guilherme Ramires de Jesus, D. Ware Branch, Laura Andreoli, Esther Rodriguez-Almaraz, Michelle Petri, Ricard Cervera, Rohan Willis, David R. Karp, Quan-Zhen Li, Hannah Cohen, Maria Laura Bertolaccini, Doruk Erkan, Jason S. Knight

Summary: This study aimed to investigate the presence, antigen specificities, and potential clinical associations of anti-neutrophil extracellular trap (anti-NET) antibodies in antiphospholipid (aPL) antibody-positive patients without lupus. The results showed that high levels of anti-NET antibodies were found in 45% of aPL-positive patients, and they were associated with clinical manifestations and the production of specific autoantibodies.

ARTHRITIS & RHEUMATOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.